Abstract

The COVID-19 pandemic has led to an increased risk of developing Type 2 Diabetes in patients with no prior history of the disease. In this systematic review, we aim to investigate the association between COVID-19 and newly diagnosed Type 2 Diabetes and identify the potential risk factors and underlying mechanisms of diabetes development in COVID-19 patients. Investigating the occurrence of diabetes following coronavirus infection was the study's goal. Out of the total 2700 cases, the mildly symptomatic (1628, 60.30%) and moderately symptomatic (815, 30.18%) patients received OPD treatment and experienced alleviation in 3–7 days; none of them required hospitalisation. Out of 2700 cases, 257 (or 9.52%) required hospitalisation due to serious illness. Our analysis shows that COVID-19 is associated with a higher risk of newly diagnosed Type 2 Diabetes, and that factors such as inflammation, insulin resistance, and genetic predisposition may contribute to the development of diabetes in COVID-19 patients. This study confirms the necessity of active glucose monitoring in hospitalised, critically unwell SARS-CoV-19-infected patients

Description